166 related articles for article (PubMed ID: 22483391)
1. 3D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA).
Ma X; Xiang G; Yap CW; Chui WK
Bioorg Med Chem Lett; 2012 May; 22(9):3194-7. PubMed ID: 22483391
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bharatam PV
J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
[TBL] [Abstract][Full Text] [Related]
3. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase.
Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R
Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
Puntambekar D; Giridhar R; Yadav MR
Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR studies on the inhibitory activity of trimethoprim analogues against Escherichia coli dihydrofolate reductase.
Vijayaraj R; Devi ML; Subramanian V; Chattaraj PK
Chem Biol Drug Des; 2012 Jun; 79(6):935-42. PubMed ID: 22304783
[TBL] [Abstract][Full Text] [Related]
7. Antifolate and antiproliferative activity of 6,8,10-triazaspiro[4.5]deca-6,8-dienes and 1,3,5-triazaspiro[5.5]undeca-1,3-dienes.
Ma X; Chui WK
Bioorg Med Chem; 2010 Jan; 18(2):737-43. PubMed ID: 20036565
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA.
Gueto C; Ruiz JL; Torres JE; Méndez J; Vivas-Reyes R
Bioorg Med Chem; 2008 Mar; 16(5):2439-47. PubMed ID: 18065233
[TBL] [Abstract][Full Text] [Related]
9. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach.
Ravichandran V; Prashantha Kumar BR; Sankar S; Agrawal RK
Eur J Med Chem; 2009 Mar; 44(3):1180-7. PubMed ID: 18687505
[TBL] [Abstract][Full Text] [Related]
10. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
11. CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductase.
Gangjee A; Lin X
J Med Chem; 2005 Mar; 48(5):1448-69. PubMed ID: 15743188
[TBL] [Abstract][Full Text] [Related]
12. Predicting anti-HIV activity of PETT derivatives: CoMFA approach.
Ravichandran V; Agrawal RK
Bioorg Med Chem Lett; 2007 Apr; 17(8):2197-202. PubMed ID: 17307357
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
Zhou X; Lin K; Ma X; Chui WK; Zhou W
Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationships for cycloguanil analogs as PfDHFR inhibitors using mathematical molecular descriptors.
Basak SC; Mills D
SAR QSAR Environ Res; 2010 Apr; 21(3-4):215-29. PubMed ID: 20544548
[TBL] [Abstract][Full Text] [Related]
15. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
16. Effects of variable selection on CoMFA coefficient contour maps in a set of triazines inhibiting DHFR.
Greco G; Novellino E; Pellecchia M; Silipo C; Vittoria A
J Comput Aided Mol Des; 1994 Apr; 8(2):97-112. PubMed ID: 8064336
[TBL] [Abstract][Full Text] [Related]
17. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
Francesconi V; Giovannini L; Santucci M; Cichero E; Costi MP; Naesens L; Giordanetto F; Tonelli M
Eur J Med Chem; 2018 Jul; 155():229-243. PubMed ID: 29886325
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
20. Triazine-benzimidazole hybrids: anticancer activity, DNA interaction and dihydrofolate reductase inhibitors.
Singla P; Luxami V; Paul K
Bioorg Med Chem; 2015 Apr; 23(8):1691-700. PubMed ID: 25792141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
